Are Wall Street Analysts Predicting McKesson Stock Will Climb or Sink?

Irving, Texas-based McKesson Corporation (MCK) distributes pharmaceuticals, medical-surgical supplies, and health and beauty care products. With a market cap of $92.1 billion, the company also develops, implements, and supports software that facilitates the integration of data throughout the health enterprise. In addition, McKesson offers analytic, care management, and patient solutions for payers.

Shares of this healthcare giant have underperformed the broader market over the past year. MCK has gained 6.7% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 27.4%. In 2026, MCK stock is down 6.6%, compared to the SPX’s 8.8% rise on a YTD basis.